中東・アフリカのGMP細胞治療用消耗品の2028年までの市場予測- 地域別分析- 製品別、細胞治療別、プロセス別、最終用途別

中東・アフリカのGMP細胞治療用消耗品市場は、2022年の4億1,805万米ドルから2028年には16億4,961万米ドルに成長すると予測、2022年から2028年までのCAGRは25.6%と推定されます。

臨床試験の増加とGMP需要の高まりが中東・アフリカのGMP細胞治療用消耗品市場を活性化する

今後数年間の消耗品市場

細胞療法は常に進化し、改善され、がん、自己免疫疾患、神経疾患などさまざまな疾患に対する新たな治療選択肢を提供しています。免疫療法は、がん治療に対する新しいアプローチです。細胞療法は現在、様々ながん種を対象に、単独で、あるいは他の治療法と組み合わせて、臨床試験で評価されています。さらに、細胞免疫療法のターゲットや新しい免疫療法のアプローチについても、臨床試験を通じて研究されています。2017年以降、FDAはリンパ腫、一部の白血病型、多発性骨髄腫を含む血液がんの治療薬として約6種類のキメラ抗原受容体（CAR）T細胞療法を承認しました。現在、すでに発売されている4つのCAR-T細胞製品（Yescarta、Tecartus、Kymriah、Breyanzi）を含め、世界中で500以上のCAR-T細胞、17のキメラ抗原受容体ナチュラルキラー（CAR-NK）細胞の試験が実施されています。また、CAR細胞療法は新しく開発された分野であり、前臨床試験や臨床試験ですでに顕著な結果が得られています。CAR細胞療法は非常に有望であり、今後数年間、承認された個別化治療の選択肢の開発をリードすると考えられています。細胞や遺伝子の領域で新たな治療法（CAR-T）が登場したことで、企業は患者の安全性を維持するとともに、臨床試験でこれらの治療法を開発、評価、テストすることが求められています。これらの新しい治療法は、患者の安全性を確保するために、科学的な基準の管理とGMPを必要とします。そのため、これらの工程で使用される機器が細胞治療薬のGMP製造環境に適合していること、すべての臨床消耗品が製造の段階と規模に適したGMP要件を満たす条件下で製造されていることが重要です。したがって、さまざまな分野での臨床試験の増加は、今後数年間、GMP細胞治療用消耗品の需要を高め、中東・アフリカのGMP細胞治療用消耗品市場を牽引すると考えられます。

中東・アフリカのGMP細胞治療用消耗品市場の概要

中東・アフリカは、UAE、サウジアラビア、南アフリカの3カ国が主要国です。2021年のこの地域のGMP細胞治療用消耗品市場は、サウジアラビアが最大でした。中東・アフリカのGMP細胞治療用消耗品市場は、予測期間中にCAGR 25.6%で成長すると予測されています。この成長は、ヘルスケア支出の増加、資金調達やヘルスケア関連政策における政府の取り組みの増加によるものと考えられます。UAEは湾岸協力会議（GCC）の先進国で、世界レベルの医療施設の整備に力を入れています。UAE政府が米国を拠点とする企業やヘルスケア施設と協力し、最先端技術の提供によりヘルスケア施設、サービス、患者ケアを向上させているため、UAEのヘルスケア施設はここ数年で大きく拡大しました。UAE政府は、同国のヘルスケアシステムにほとんど資金を提供しています。国際貿易局米国商務省によると、UAEの医療費は2023年までに183億米ドルに増加すると予測されています。さらに、Dubai International Pharmaceuticals &Technologies Conference &Exhibition（DUPHAT）は、UAEで医療観光が拡大していることを報告しました。UAEの医療観光産業は、2018年に121億AED（32億9,000万米ドル）を生み出し、年間成長率5.5%で成長しました。同国は～350,118人の訪問者を獲得し、2019年のヘルスツーリズムの到着者数は前年比4%で増加しました。これは、年間50万人の医療観光客に上昇することが予想されます。さらに、同国の人口増加により、がんを含むさまざまな感染症や病気にかかりやすくなっており、細胞ベースの治療法に対する膨大な需要が生まれています。このように、医療観光客の増加、政府支出の増加、細胞療法の採用拡大が、GMP細胞治療用消耗品の需要を高め、予測期間中にUAEのGMP細胞治療用消耗品市場の成長を促進すると考えられます。

中東・アフリカのGMP細胞治療用消耗品市場の収益と2028年までの予測（US$Million）

中東・アフリカのGMP細胞治療用消耗品市場のセグメンテーション

中東・アフリカのGMP細胞治療用消耗品市場は、製品、細胞治療、プロセス、最終用途、国に基づいてセグメント化されています。

製品別では、中東・アフリカのGMP細胞治療用消耗品市場は、キット、試薬/分子生物学試薬、成長因子/サイトカインおよびインターロイキン（タンパク質および核酸精製バッファーを含む）、その他に分類されます。2022年の中東・アフリカのGMP細胞治療用消耗品市場では、キット部門が最大のシェアを占めています。

細胞療法に基づき、中東・アフリカのGMP細胞治療用消耗品市場は、NK細胞療法、幹細胞療法、T細胞療法、およびその他に区分されます。T細胞療法セグメントは、2022年に中東・アフリカのGMP細胞治療用消耗品市場で最大のシェアを登録しました。

プロセス別に見ると、中東・アフリカのGMP細胞治療用消耗品市場は、細胞収集と特性評価/選別・分離、細胞培養と拡大/調製、凍結保存、細胞加工と製剤、細胞分離と活性化、細胞分配/ハンドリング、プロセスモニタリングと制御/管理/品質保証、その他に分類されます。2022年の中東・アフリカのGMP細胞治療用消耗品市場では、細胞の収集と特性評価/選別・分離分野が最大のシェアを占めています。

エンドユースに基づき、中東・アフリカのGMP細胞治療用消耗品市場は、臨床、商業、研究に区分されます。2022年の中東・アフリカのGMP細胞治療用消耗品市場は、臨床分野が最大のシェアを占めています。

国別に見ると、中東・アフリカのGMP細胞治療用消耗品市場は、サウジアラビア、南アフリカ、UAE、その他中東・アフリカに区分されます。2022年の中東・アフリカのGMP細胞治療用消耗品市場は、サウジアラビアが独占しました。

Bio-Techne Corp;BPS Bioscience Inc;Corning Inc;FUJIFILM Irvine Scientific Inc;Global Life Sciences Solutions USA LLC;Lonza Group AG;Merck KGaA;Miltenyi Biotec BV &Co KG;Sartorius AG;and Thermo Fisher Scientific Incは、中東・アフリカのGMP細胞治療用消耗品市場で活動している主要企業です。

目次

第1章 イントロダクション

第2章 中東・アフリカのGMP細胞治療用消耗品市場-主要な要点

第3章 調査手法

• カバレッジ
• 2次調査
• 1次調査

第4章 中東・アフリカのGMP細胞治療用消耗品市場- 市場情勢

• 中東・アフリカのPEST分析
• 専門家の見解

第5章 中東・アフリカのGMP細胞治療用消耗品市場-主要市場力学

• 市場促進要因
  • 研究開発と創薬活動の活発化
  • 戦略的提携の増加
• 市場抑制要因
  • 厳しい規制政策
• 市場機会
  • 細胞・遺伝子治療（CGT）製品に関する規制当局の承認取得の増加
• 今後の動向
  • 臨床試験の増加とGMP需要の増加
• 影響度分析

第6章 GMP細胞治療用消耗品市場-中東・アフリカ分析

• 中東・アフリカのGMP細胞治療用消耗品市場収益と予測・分析

第7章 中東・アフリカのGMP細胞治療用消耗品市場-2028年までの収益と予測-製品別

• 中東・アフリカのGMP細胞治療用消耗品市場の収益シェア（製品別）：2021年・2028年（%）
• キット
• 試薬/分子生物学試薬
• 成長因子／サイトカイン／インターロイキン（タンパク質・核酸精製用バッファーを含む）
• その他

第8章 中東・アフリカのGMP細胞治療用消耗品市場の分析と2028年までの予測（細胞治療分野別

• 中東・アフリカのGMP細胞治療用消耗品市場：細胞療法別2021年・2028年（%）
• NK細胞療法
• ステムセルセラピー
• T細胞療法
• その他

第9章 中東・アフリカのGMP細胞治療用消耗品市場- エンドユース別の収益と2028年までの予測

• 中東・アフリカのGMP細胞治療用消耗品市場2021年・2028年エンドユーザー別売上高シェア（%）
• 臨床用
• 商業
• 調査

第10章 中東・アフリカのGMP細胞治療用消耗品市場の収益と2028年までの予測（プロセス別

• 中東・アフリカのGMP細胞治療用消耗品市場2021年・2028年エンドユーザー別売上高シェア（%）
• 細胞の収集と特性評価/選別と分離
• 細胞培養・拡大/調製
• 凍結保存
• 細胞加工・製剤化
• 細胞の単離と活性化
• 細胞流通・ハンドリング
• プロセスのモニタリングとコントロール/管理/品質保証
• その他

第11章 中東・アフリカのGMP細胞治療用消耗品市場-2028年までの収益と予測- 国別分析

• 中東・アフリカ
  • UAE（アラブ首長国連邦）
  • サウジアラビア
  • 南アフリカ
  • 中東・アフリカの他の地域

第12章 GMP細胞治療用消耗品市場- 業界情勢

• GMP細胞治療用消耗品市場の成長戦略
• 無機的成長戦略
• 有機的成長戦略

第13章 企業プロファイル

• Sartorius AG
• Thermo Fisher Scientific Inc
• Miltenyi Biotec BV & Co KG
• Bio-Techne Corp
• Corning Inc
• FUJIFILM Irvine Scientific Inc
• Lonza Group AG
• BPS Bioscience Inc
• Merck KGaA
• Global Life Sciences Solutions USA LLC

第14章 付録

List Of Tables

• Table 1. UAE GMP Cell Therapy Consumables Market, by Product - Revenue and Forecast to 2028 (US$ Million)
• Table 2. UAE GMP Cell Therapy Consumables Market, by Cell Therapy - Revenue and Forecast to 2028 (US$ Million)
• Table 3. UAE GMP Cell Therapy Consumables Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
• Table 4. UAE GMP Cell Therapy Consumables Market, by Process - Revenue and Forecast to 2028 (US$ Million)
• Table 5. Saudi Arabia GMP Cell Therapy Consumables Market, by Product - Revenue and Forecast to 2028 (US$ Million)
• Table 6. Saudi Arabia GMP Cell Therapy Consumables Market, by Cell Therapy - Revenue and Forecast to 2028 (US$ Million)
• Table 7. Saudi Arabia GMP Cell Therapy Consumables Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
• Table 8. Saudi Arabia GMP Cell Therapy Consumables Market, by Process - Revenue and Forecast to 2028 (US$ Million)
• Table 9. South Africa GMP Cell Therapy Consumables Market, by Product - Revenue and Forecast to 2028 (US$ Million)
• Table 10. South Africa GMP Cell Therapy Consumables Market, by Cell Therapy - Revenue and Forecast to 2028 (US$ Million)
• Table 11. South Africa GMP Cell Therapy Consumables Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
• Table 12. South Africa GMP Cell Therapy Consumables Market, by Process - Revenue and Forecast to 2028 (US$ Million)
• Table 13. Rest of MEA GMP Cell Therapy Consumables Market, by Product - Revenue and Forecast to 2028 (US$ Million)
• Table 14. Rest of MEA GMP Cell Therapy Consumables Market, by Cell Therapy - Revenue and Forecast to 2028 (US$ Million)
• Table 15. Rest of MEA GMP Cell Therapy Consumables Market, by End Use - Revenue and Forecast to 2028 (US$ Million)
• Table 16. Rest of MEA GMP Cell Therapy Consumables Market, by Process - Revenue and Forecast to 2028 (US$ Million)
• Table 17. Recent Inorganic Growth Strategies in the GMP Cell Therapy Consumables Market
• Table 18. Recent Organic Growth Strategies in GMP Cell Therapy Consumables Market
• Table 19. Glossary of Terms

List Of Figures

• Figure 1. MEA GMP Cell Therapy Consumables Market Segmentation
• Figure 2. MEA GMP Cell Therapy Consumables Market, by Country
• Figure 3. MEA GMP Cell Therapy Consumables Market Overview
• Figure 4. Kits Segment Held the Largest Share of Product Segment in MEA GMP Cell Therapy Consumables Market
• Figure 5. UAE Expected to Show Remarkable Growth During Forecast Period
• Figure 6. MEA: PEST Analysis
• Figure 7. Experts' Opinion
• Figure 8. MEA GMP Cell Therapy Consumables Market: Impact Analysis of Drivers and Restraints
• Figure 9. MEA GMP Cell Therapy Consumables Market - Revenue Forecast and Analysis - 2019-2028
• Figure 10. MEA GMP Cell Therapy Consumables Market Revenue Share, by Product 2021 & 2028 (%)
• Figure 11. Kits: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 12. Reagents/ Molecular Biology Reagents: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 13. Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers): MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 14. Others: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 15. MEA GMP Cell Therapy Consumables Market, by Cell Therapy 2021 & 2028 (%)
• Figure 16. NK Cell Therapy: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 17. Stem Cell Therapy: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 18. T-cell Therapy: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 19. Other Applications: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 20. MEA GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
• Figure 21. Clinical: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 22. Commercial: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 23. Research: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 24. MEA GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
• Figure 25. Cell Collection and Characterization/Sorting and Separation: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 26. Cell Culture and Expansion/Preparation: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 27. Cryopreservation: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 28. Cell Processing and Formulation: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 29. Cell Isolation and Activation: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 30. Cell Distribution/Handling: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 31. Process Monitoring and Control/Readministration/Quality Assurance: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 32. Other: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 33. MEA: GMP Cell Therapy Consumables Market, by Key Country - Revenue (2021) (US$ Million)
• Figure 34. UAE: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 35. Saudi Arabia: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 36. South Africa: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 37. Rest of MEA: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• Figure 38. Growth Strategies in GMP Cell Therapy Consumables Market

The Middle East & Africa GMP cell therapy consumables market is expected to grow from US$ 418.05 million in 2022 to US$ 1,649.61 million by 2028; it is estimated to grow at a CAGR of 25.6% from 2022 to 2028.

Increasing Clinical Trials and Rising GMP Demand to Fuel Middle East & Africa GMP Cell Therapy

Consumables Market in Coming Years

Cell therapies are constantly evolving, improving, and providing new treatment options for various disorders, such as cancer, autoimmune disorders, and neurological disorders. Immunotherapy is a new approach to cancer treatment. Cell therapies are currently being evaluated in clinical trials for various cancer types, separately and combined with other treatments. Additionally, the cellular immunotherapy targets and new immunotherapy approaches are investigated through clinical trials. Since 2017, FDA has approved approximately six chimeric antigen receptor (CAR) T-cell therapies for the treatment of blood cancer, including lymphomas, some leukemia forms, and multiple myeloma. More than 500 CAR-T and 17 chimeric antigen receptor natural killer (CAR-NK) cell trials are currently being conducted across the world, including the four CAR-T cell products-Yescarta, Tecartus, Kymriah, and Breyanzi-that are already available in the market. Further, the CAR cellular therapies field is newly developed, and preclinical and clinical studies have already shown remarkable results. It is believed that CAR-based cellular therapies are profoundly promising and will lead the development of approved personalized therapeutic options in the coming years. With new therapeutic modalities emerging in the cell and gene space (CAR-T), companies are required to develop, evaluate, and test these therapies in clinical trials, along with maintaining patient safety. These emerging therapies require a scientific standard of controls and GMPs to ensure patient safety. Thus, it is important to ensure that the equipment used during these processes is compatible with GMP manufacturing environments for cell therapies and that all clinical consumables are manufactured under conditions that fulfill GMP requirements appropriate for the phase and scale of manufacturing. Therefore, the increasing clinical trials in various fields will raise the demand for GMP cell therapy consumables in the coming years, thereby driving the Middle East & Africa GMP cell therapy consumables market .

Middle East & Africa GMP Cell Therapy Consumables Market Overview

The UAE, Saudi Arabia, and South Africa are the three major countries in the Middle East & Africa. Saudi Arabia was the largest market for GMP cell therapy consumables in this region in 2021. The Middle East & Africa GMP cell therapy consumables market is anticipated to grow at a CAGR of 25.6% during the forecast period; this growth is attributed to the rising healthcare expenditure and increasing government initiatives in funding and healthcare-related policies. The UAE is a developed country in the Gulf Cooperation Council (GCC) that is focused on creating world-class health facilities. The healthcare facilities in the UAE expanded significantly in the last few years as the UAE government is collaborating with US-based companies and healthcare facilities, improving healthcare facilities, services, and patient care by providing cutting-edge technologies. The UAE government mostly funds the country's healthcare system. According to the International Trade Administration US Department of Commerce, healthcare spending in UAE is forecasted to rise to US$ 18.3 billion by 2023. Additionally, the Dubai International Pharmaceuticals & Technologies Conference & Exhibition (DUPHAT) reported that medical tourism is expanding in the UAE. The medical tourism industry in the UAE generated AED 12.1 billion (US$ 3.29 billion) in 2018, witnessing a 5.5% annual growth rate. The country recorded ~350,118 visitors, registering a rise of 4% in health tourism arrivals in 2019 from the previous year. It is anticipated that this will rise to 500,000 medical tourists per year. Further, the growing population in the country is prone to various infections and diseases, including cancer, creating immense demand for cell-based therapies. Thus, the increasing medical tourism, rising government expenditure, and growing adoption of cell therapies will increase the demand for GMP cell therapy consumables and propel the growth of the GMP cell therapy consumables market in the UAE during the forecast period.

Middle East & Africa GMP Cell Therapy Consumables Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa GMP Cell Therapy Consumables Market Segmentation

The Middle East & Africa GMP cell therapy consumables market is segmented based on product, cell therapy, process, end use, and country.

Based on product, the Middle East & Africa GMP cell therapy consumables market is segmented into kits, reagents/molecular biology reagents, growth factors/cytokines and interleukins (including protein and nucleic acid purification buffers), and others. The kits segment held the largest share of the Middle East & Africa GMP cell therapy consumables market in 2022.

Based on cell therapy, the Middle East & Africa GMP cell therapy consumables market is segmented into NK cell therapy, stem cell therapy, T-cell therapy, and others. The T-cell therapy segment registered the largest share of the Middle East & Africa GMP cell therapy consumables market in 2022.

Based on process, the Middle East & Africa GMP cell therapy consumables market is segmented into cell collection and characterization/sorting and separation, cell culture and expansion/preparation, cryopreservation, cell processing and formulation, cell isolation and activation, cell distribution/handling, process monitoring and control/readministration/quality assurance, and others. The cell collection and characterization/sorting and separation segment held the largest share of the Middle East & Africa GMP cell therapy consumables market in 2022.

Based on end use, the Middle East & Africa GMP cell therapy consumables market is segmented into clinical, commercial, and research. The clinical segment held the largest share of the Middle East & Africa GMP cell therapy consumables market in 2022.

Based on country, the Middle East & Africa GMP cell therapy consumables market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa GMP cell therapy consumables market in 2022.

Bio-Techne Corp; BPS Bioscience Inc; Corning Inc; FUJIFILM Irvine Scientific Inc; Global Life Sciences Solutions USA LLC; Lonza Group AG; Merck KGaA; Miltenyi Biotec BV & Co KG; Sartorius AG; and Thermo Fisher Scientific Inc are the leading companies operating in Middle East & Africa GMP cell therapy consumables market.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa GMP cell therapy consumables market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa GMP cell therapy consumables market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the GMP cell therapy consumables market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

• 1.1 Study Scope
• 1.2 The Insight Partners Research Report Guidance
• 1.3 Market Segmentation
  • 1.3.1 MEA GMP Cell Therapy Consumables Market - by Product
  • 1.3.2 MEA GMP Cell Therapy Consumables Market - by Cell Therapy
  • 1.3.3 MEA GMP Cell Therapy Consumables Market - by End Use
  • 1.3.4 MEA GMP Cell Therapy Consumables Market - by End Use
  • 1.3.5 MEA GMP Cell Therapy Consumables Market - by Country

2. MEA GMP Cell Therapy Consumables Market - Key Takeaways

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. MEA GMP Cell Therapy Consumables Market - Market Landscape

• 4.1 Overview
• 4.2 MEA PEST Analysis
• 4.3 Experts' Opinion

5. MEA GMP Cell Therapy Consumables Market - Key Market Dynamics

• 5.1 Market Drivers
  • 5.1.1 Rise in Research & Development and Drug Discovery
  • 5.1.2 Increase in Strategic Collaborations
• 5.2 Market Restraints
  • 5.2.1 Stringent Regulatory Policies
• 5.3 Market Opportunities
  • 5.3.1 Growing Regulatory Approvals for Cell and Gene Therapy (CGT) Product
• 5.4 Future Trends
  • 5.4.1 Increasing Clinical Trials and Rising GMP Demand
• 5.5 Impact Analysis

6. GMP Cell Therapy Consumables Market - MEA Analysis

• 6.1 MEA GMP Cell Therapy Consumables Market Revenue Forecast and Analysis

7. MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 - by Product

• 7.1 Overview
• 7.2 MEA GMP Cell Therapy Consumables Market Revenue Share, by Product 2021 & 2028 (%)
• 7.3 Kits
  • 7.3.1 Overview
  • 7.3.2 Kits: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 7.4 Reagents/ Molecular Biology Reagents
  • 7.4.1 Overview
  • 7.4.2 Reagents/ Molecular Biology Reagents: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 7.5 Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers)
  • 7.5.1 Overview
  • 7.5.2 Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers): MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 7.6 Others
  • 7.6.1 Overview
  • 7.6.2 Others: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)

8. MEA GMP Cell Therapy Consumables Market Analysis and Forecasts to 2028 - by Cell Therapy

• 8.1 Overview
• 8.2 MEA GMP Cell Therapy Consumables Market, by Cell Therapy 2021 & 2028 (%)
• 8.3 NK Cell Therapy
  • 8.3.1 Overview
  • 8.3.2 NK Cell Therapy: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 8.4 Stem Cell Therapy
  • 8.4.1 Overview
  • 8.4.2 Stem Cell Therapy: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 8.5 T-cell Therapy
  • 8.5.1 Overview
  • 8.5.2 T-cell Therapy: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 8.6 Others
  • 8.6.1 Overview
  • 8.6.2 Others: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)

9. MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 - by End Use

• 9.1 Overview
• 9.2 MEA GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
• 9.3 Clinical
  • 9.3.1 Overview
  • 9.3.2 Clinical: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 9.4 Commercial
  • 9.4.1 Overview
  • 9.4.2 Commercial: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 9.5 Research
  • 9.5.1 Overview
  • 9.5.2 Research: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)

10. MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 - by Process

• 10.1 Overview
• 10.2 MEA GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
• 10.3 Cell Collection and Characterization/Sorting and Separation
  • 10.3.1 Overview
  • 10.3.2 Cell Collection and Characterization/ Sorting and Separation: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 10.4 Cell Culture and Expansion/Preparation
  • 10.4.1 Overview
  • 10.4.2 Cell Culture and Expansion/Preparation: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 10.5 Cryopreservation
  • 10.5.1 Overview
  • 10.5.2 Cryopreservation: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 10.6 Cell Processing and Formulation
  • 10.6.1 Overview
  • 10.6.2 Cell Processing and Formulation: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 10.7 Cell Isolation and Activation
  • 10.7.1 Overview
  • 10.7.2 Cell Isolation and Activation: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 10.8 Cell Distribution/Handling
  • 10.8.1 Overview
  • 10.8.2 Cell Distribution/Handling: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 10.9 Process Monitoring and Control/Readministration/Quality Assurance
  • 10.9.1 Overview
  • 10.9.2 Process Monitoring and Control/Readministration/Quality Assurance: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
• 10.10 Other
  • 10.10.1 Overview
  • 10.10.2 Other: MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)

11. MEA GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 - Country Analysis

• 11.1 Overview
  • 11.1.1 MEA: GMP Cell Therapy Consumables Market, by Country, 2021 & 2028 (%)
    • 11.1.1.1 UAE: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.1.1 Overview
      • 11.1.1.1.2 UAE: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.1.3 UAE: GMP Cell Therapy Consumables Market, by Product, 2019-2028 (US$ Million)
      • 11.1.1.1.4 UAE: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019-2028 (US$ Million)
      • 11.1.1.1.5 UAE: GMP Cell Therapy Consumables Market, by End Use, 2019-2028 (US$ Million)
      • 11.1.1.1.6 UAE GMP Cell Therapy Consumables Market, by Process, 2019-2028 (US$ Million)
    • 11.1.1.2 Saudi Arabia: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.2.1 Overview
      • 11.1.1.2.2 Saudi Arabia: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.2.3 Saudi Arabia: GMP Cell Therapy Consumables Market, by Product, 2019-2028 (US$ Million)
      • 11.1.1.2.4 Saudi Arabia: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019-2028 (US$ Million)
      • 11.1.1.2.5 Saudi Arabia: GMP Cell Therapy Consumables Market, by End Use, 2019-2028 (US$ Million)
      • 11.1.1.2.6 Saudi Arabia GMP Cell Therapy Consumables Market, by Process, 2019-2028 (US$ Million)
    • 11.1.1.3 South Africa: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.3.1 Overview
      • 11.1.1.3.2 South Africa: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.3.3 South Africa: GMP Cell Therapy Consumables Market, by Product, 2019-2028 (US$ Million)
      • 11.1.1.3.4 South Africa: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019-2028 (US$ Million)
      • 11.1.1.3.5 South Africa: GMP Cell Therapy Consumables Market, by End Use, 2019-2028 (US$ Million)
      • 11.1.1.3.6 South Africa GMP Cell Therapy Consumables Market, by Process, 2019-2028 (US$ Million)
    • 11.1.1.4 Rest of MEA: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.4.1 Overview
      • 11.1.1.4.2 Rest of MEA: GMP Cell Therapy Consumables Market - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.1.4.3 Rest of MEA: GMP Cell Therapy Consumables Market, by Product, 2019-2028 (US$ Million)
      • 11.1.1.4.4 Rest of MEA: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019-2028 (US$ Million)
      • 11.1.1.4.5 Rest of MEA: GMP Cell Therapy Consumables Market, by End Use, 2019-2028 (US$ Million)
      • 11.1.1.4.6 Rest of MEA GMP Cell Therapy Consumables Market, by Process, 2019-2028 (US$ Million)

12. GMP Cell Therapy Consumables Market - Industry Landscape

• 12.1 Overview
• 12.2 Growth Strategies in GMP Cell Therapy Consumables Market
• 12.3 Inorganic Growth Strategies
  • 12.3.1 Overview
• 12.4 Organic Growth Strategies
  • 12.4.1 Overview

13. Company Profiles

• 13.1 Sartorius AG
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
• 13.2 Thermo Fisher Scientific Inc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
• 13.3 Miltenyi Biotec BV & Co KG
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
• 13.4 Bio-Techne Corp
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
• 13.5 Corning Inc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
• 13.6 FUJIFILM Irvine Scientific Inc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
• 13.7 Lonza Group AG
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
• 13.8 BPS Bioscience Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
• 13.9 Merck KGaA
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
• 13.10 Global Life Sciences Solutions USA LLC
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

• 14.1 About The Insight Partners
• 14.2 Glossary of Terms